| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.21B | $3.78B | $4.30B |
| YoY Revenue Growth % | -14.9% | -12.3% | — |
| Gross Profit | $514.2M | $689.0M | — |
| Gross Margin % | 16.0% | 18.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$416.0M | -$126.4M | $141.6M |
| Operating Margin % | -13.0% | -3.3% | 3.3% |
| Net Income (GAAP) | -$621.2M | -$189.0M | $62.4M |
| EBITDA (Normalized) | -$320.2M | $3.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$4.9M | $106.2M | $345.2M |
| Capital Expenditures (CapEx) | $119.8M | $161.9M | — |
| Free Cash Flow (FCF) | -$124.6M | -$55.7M | $345.2M |
| FCF Margin % | -3.9% | -1.5% | 8.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -21.3% | — |
| Cash & Short-Term Equivalents | $136.1M | $150.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $92.2M | $620.1M | — |